Basics Apogee Therapeutics, Inc. IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $2.26B Activated in VL: True Average Daily Range Avg Daily Range: $1.10 | 2.85% Avg Daily Range (30 D): $0.86 | 2.28% Avg Daily Range (90 D): $0.99 | 2.51% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .63M Trade Size Avg Trade Size (Sh.): 55 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 1,081 Avg Inst. Trade: $2.65M Avg Inst. Trade (30 D): $2.14M Avg Inst. Trade (90 D): $2.33M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.73M Avg Closing Trade (30 D): $2.92M Avg Closing Trade (90 D): $3.9M Avg Closing Volume: 87.44K     News Jul 7, 2025 @ 10:00 AM Apogee Therapeutics Announces Positive 16-Week Dat... Source: Apogee Therapeutics Jul 6, 2025 @ 10:00 PM Apogee Therapeutics to Host Conference Call to Rep... Source: Apogee Therapeutics, Inc. May 12, 2025 @ 10:00 AM Apogee Therapeutics Announces Positive Interim Res... Source: N/A May 1, 2025 @ 12:00 PM Apogee Therapeutics to Participate at the Bank of ... Source: N/A Mar 3, 2025 @ 11:00 AM Apogee Therapeutics Announces Positive Interim Pha... Source: Apogee Therapeutics, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.13 $-.95 Diluted EPS $-1.13 $-.95 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -66.1M $ -55.34M Operating Income / Loss $ $ -73.17M $ -63.1M Cost of Revenue $ $ $ Net Cash Flow $ $ 17.28M $ -34.87M PE Ratio     Splits Jan 08, 2008:   1:50